NCT01735240View on ClinicalTrials.gov

Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Asthma,Pharmacokinetics,Cmax,Tmax,λz,AUC,Ketoconazole,Metabolite
Interventions
DRUG

AZD5069

AZD5069 15 mg (3x5 mg capsules) single administration

DRUG

Ketoconazole

Ketoconazole 400 mg (2x200 mg tablets)

Trial Locations (1)

Unknown

London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01735240 - Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally. | Biotech Hunter | Biotech Hunter